Results 131 to 140 of about 14,756 (172)

Studies on enmetazobactam clarify mechanisms of widely used β-lactamase inhibitors. [PDF]

Proc Natl Acad Sci U S A, 2022
Lang PA, Raj R, Tumber A, Lohans CT, Rabe P, Robinson CV, Brem J, Schofield CJ.   +7 more
europepmc   +1 more source

In Vitro Activity of Novel β-Lactam/β-Lactamase Inhibitors Against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Enterobacterales</i> in Korea. [PDF]

Antibiotics (Basel)
Moon S, Yi J, Ko MK, Sim YK, Kim KH.
europepmc   +1 more source

Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis-Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase Inhibitors. [PDF]

Open Forum Infect Dis, 2023
Yasmin M, Rojas LJ, Marshall SH, Hujer AM, Cmolik A, Marshall E, Boucher HW, Vila AJ, Soldevila M, Diene SM, Rolain JM, Bonomo RA.   +11 more
europepmc   +1 more source

Perspectives on Metallo-β-Lactamase Inhibitors: Challenges and Implications of Metallo-β-Lactamase Variants. [PDF]

Iran J Public Health
Lee JH, Kim DW, Lee SH.
europepmc   +1 more source

Antimicrobial activity of cephamycins and β-lactam/β-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula. [PDF]

Sci Rep
Wi YM, Choi JY, Lee DE, Jun SH, Kwon KT, Ko KS.   +5 more
europepmc   +1 more source

What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. [PDF]

J Antimicrob Chemother
Assefa GM, Roberts JA, Mohammed SA, Sime FB.   +3 more
europepmc   +1 more source

Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia. [PDF]

Antibiotics (Basel)
Viscardi S, Topola E, Sobieraj J, Duda-Madej A.   +3 more
europepmc   +1 more source

Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Allander L, Vickberg K, Fermér E, Söderhäll T, Sandegren L, Lagerbäck P, Tängdén T.   +6 more
europepmc   +1 more source

Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant Enterobacterales. [PDF]

JAC Antimicrob Resist
Lin CK, Page A, Lohsen S, Haider AA, Waggoner J, Smith G, Babiker A, Jacob JT, Howard-Anderson J, Satola SW.   +9 more
europepmc   +1 more source

Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in Enterobacterales. [PDF]

Microbiol Spectr
Wachino J-i, Jin W, Norizuki C, Kimura K, Tsuji M, Kurosaki H, Arakawa Y.   +6 more
europepmc   +1 more source